Veeda Board announces appointment of Dr. Mahesh Bhalgat as Group – CEO

AHMEDABAD, India - March 7, 2024 - PRLog -- Veeda Clinical Research Limited today announced the appointment of Dr. Mahesh Bhalgat as the Group – CEO. Dr. Mahesh Bhalgat is an accomplished leader and professional with more than three decades of a successful career in developing business strategies, driving growth, spearheading multiple initiatives across several verticals, and managing operations in diverse businesses including, Biopharmaceuticals, Vaccines, Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO), Agricultural Biotechnology, and Research reagents and services space.

At Veeda, Dr. Mahesh will provide strategic leadership and drive the integration of different business segments to build a multinational integrated technology-enabled, clinical research organization by overseeing a diverse portfolio of research services of Veeda group companies, which includes Preclinical Research business (Bioneeds India Pvt. Ltd.), and Clinical Research entity (Veeda Clinical Research Limited).

"The joining of Mahesh, a highly accomplished Pharma-Biotech industry veteran reflects the strong commitment across the group companies to becoming a leading Contract Research Group, by expanding footprint beyond India and offering comprehensive set of research services for diverse clients serving both early and late-stage global clinical development programs. Mahesh brings global experience from organizations such as Amgen, Sanofi, Syngene and others to drive international standards into Veeda. He will focus on business growth, including mergers and acquisitions, leveraging technology and client centricity to bring the best of Veeda's service portfolios to the global clients." said Mr. Vivek Chhachhi, Board Member and Director at Veeda Clinical Research Limited.

Dr. Mahesh has vast experience of being in a senior leadership roles. Prior to joining Veeda, Mahesh was the COO for Syngene International (Biocon Group Company), India's largest CRO & CDMO company. Prior to that, he was the COO and Executive Director for Sanofi in Hyderabad, where he was responsible for initiating the first-ever Indian manufacturing operation for injectable polio vaccine. Mahesh started his India career with Biological E Limited, which he joined after 20 years in North America pursuing his study and working with multi-national drug development companies, which include Amgen and Monsanto and Thermofisher. Mahesh developed a deep interest in research sciences while he was pursuing his Graduation in Pharmaceutical Sciences from the University of Mumbai. His pursuit for learning led him to Salt Lake City where he completed his doctorate at the University of Utah.

About Veeda Clinical Research Limited:

Veeda Clinical Research Limited ("Veeda") is one of the largest independent, full-service clinical research organizations, headquartered in Ahmedabad, India. Veeda offers a range of bioequivalence studies and early and late phase clinical trials. Veeda has successfully completed several regulatory inspections and is approved by USFDA, UK MHRA, ANVISA (Brazil), and WHO. Veeda has experience in conducting complex clinical studies. Visit https://www.veedacr.com/